Adaptive Bayesian compound designs for dose finding studies
From MaRDI portal
Recommendations
Cites work
- scientific article; zbMATH DE number 47310 (Why is no real title available?)
- A Method for Obtaining and Analyzing Sensitivity Data
- A Stochastic Approximation Method
- Adaptive designs for selecting drug combinations based on efficacy-toxicity response
- Bayesian decision procedures based on logistic regression models for dose-finding studies
- Bayesian optimal designs for phase I clinical trials
- Compound optimal designs for percentile estimation in dose-response models with restricted design intervals
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Easy-to-implement Bayesian methods for dose-escalation studies in healthy volunteers
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
- Markov chains for exploring posterior distributions. (With discussion)
- Miscellanea. A stopping rule for the continual reassessment method
- Nonlinear Experiments: Optimal Design and Inference Based on Likelihood
- Optimal Bayesian-feasible dose escalation for cancer phase I trials
- Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
- Selection of Dose Levels for Estimating a Percentage Point of a Logistic Quantal Response Curve
- Sequential Experimental Designs for Generalized Linear Models
- Simulation-based sequential Bayesian design
- Statistical Methods for Dose‐Finding Experiments
Cited in
(18)- scientific article; zbMATH DE number 5898591 (Why is no real title available?)
- Developments of the total entropy utility function for the dual purpose of model discrimination and parameter estimation in Bayesian design
- A pseudo-marginal sequential Monte Carlo algorithm for random effects models in Bayesian sequential design
- Adaptive Dc-optimal designs for dose finding based on a continuous efficacy endpoint
- A combined proof of concept and dose finding study with multiple endpoints: A Bayesian adaptive design in chronic prostatitis/chronic pelvic pain syndrome
- Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
- A Bayesian dose-finding design for drug combination trials with delayed toxicities
- A Review of Modern Computational Algorithms for Bayesian Optimal Design
- Response-adaptive randomization in clinical trials: from myths to practical considerations
- Bayesian sequential design for copula models
- Implementation of a Bayesian Design in a Dose‐Escalation Study of an Experimental Agent in Healthy Volunteers
- Bayesian adaptive \(N\)-of-1 trials for estimating population and individual treatment effects
- Sequential Monte Carlo for Bayesian sequentially designed experiments for discrete data
- Adaptive clinical trial designs for phase I cancer studies
- Evaluation of the Fisher information matrix in nonlinear mixed effect models using adaptive Gaussian quadrature
- Bayesian dose finding for combined drugs with discrete and continuous doses
- A Laplace-based algorithm for Bayesian adaptive design
- scientific article; zbMATH DE number 1984442 (Why is no real title available?)
This page was built for publication: Adaptive Bayesian compound designs for dose finding studies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q434557)